NANO-X IMAGING (NNOX) announced that its deep-learning medical imaging analytics subsidiary, Nanox.AI secured the recommendation of the National Institute for Health and Care Excellence, the UK’s clinical standards and reimbursement body. NICE has included both Nanox AI bone solutions in an Early Value Assessment at National Health Service hospitals in the UK. NICE has included Nanox AI’s HealthVCF and HealthOST, along with three other AI solutions, for evaluation in NHS hospitals to provide evidence of how AI can help support the detection of vertebral fragility fractures, while further data on their benefits is gathered and assessed. HealthOST is the evolution of HealthVCF, which was evaluated in the AI-enabled Detection of OsteoPorosis study.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano-X Imaging Ltd. Reports Q3 2025 Financial Results
- Nano-X Imaging Ltd. Balances Growth and Challenges in Latest Earnings Call
- Nano-X Imaging Reports Q3 2025 Results and Strategic Advances
- Nano-X Imaging sees FY26 revenue reaching $35M, consensus $22.49M
- Nano-X Imaging reports Q3 EPS (15c) vs. (15c) last year